Our client, a global MedTech company, was in the process of developing a strategy for the obesity and metabolic disease market.
They wanted to understand how their existing portfolio met the needs of the market and where the opportunities to improve and develop new products may exist.
Focusing on obesity with Type 2 Diabetes and/or NASH, we conducted 45 web-assisted TDIs with ‘referrers’ (PCPs / Gis / Heps / Endos and Bariatric Surgeons) and ‘proceduralists’ (Advanced / Interventional GIs) in France, Italy, UK, and USA to identify the market opportunity for endoscopic weight loss devices and procedures.
The findings from our research provided our client with the insights they needed in the following four areas:
Market size and outlook: The size of the endoscopic market in the obesity and metabolic space, areas with the greatest potential and the future outlook for use of medical technologies.
Key competitors: Changes within the obesity and metabolic market landscape of the previous five years, awareness of key players, and perceptions of competitor clinical data.
Patient pathways: Clinical assessment of current and investigational procedures, patient referral patterns and the challenges in the procedural decision process.
Payer landscape: Physicians’ perception of the payer landscape and challenges faced with approvals for endoscopic procedures.